Answer
Yes, the Aspen Co-Trimoxazole for Infusion (sulfamethoxazole + trimethoprim) product is indicated for both treatment and prevention of Pneumocystis jirovecii pneumonitis (PJP) in adults and children aged at least 6 weeks when caused by sensitive organisms.
Sources for this answer
- Co-Trimoxazole 16 mg/ 80 mg per ml for Infusion.Aspen · emc · SmPC §4.1 Therapeutic Indications · Version 17Document updated
Sources checked